TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE Trademark

Trademark Overview


On Wednesday, March 7, 2018, a trademark application was filed for TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE with the United States Patent and Trademark Office. The USPTO has given the TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE trademark a serial number of 87824901. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2019. This trademark is owned by Ocular Science, Inc.. The TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic preparations
timolol / brimonidine tartrate / dorzolamide ophthalmic solution 0.5% / 0.2% / 2% omni by ocular science

General Information


Serial Number87824901
Word MarkTIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% OMNI BY OCULAR SCIENCE
Filing DateWednesday, March 7, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 8, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 10, 2018

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION 0.5% / 0.2% / 2%" AND "BY OCULAR SCIENCE"
Description of MarkThe mark consists of the words "Timolol / Brimonidine Tartrate / Dorzolamide Ophthalmic Solution 0.5% / 0.2% / 2%" above the words of "OMNI by OCULAR SCIENCE". The "Timolol / Brimonidine Tartrate /" words are above the "Dorzolamide Ophthalmic Solution" words. The "Dorzolamide Ophthalmic Solution" words are above the "0.5% / 0.2% / 2%" words. The "Timolol / Brimonidine Tartrate / Dorzolamide Ophthalmic Solution 0.5% / 0.2% / 2%" words are superimposed over a background of stripes. The word "OMNI" is above the words "by OCULAR SCIENCE". The words "by OCULAR SCIENCE" is centered with respect to "OMNI". The lettering for "OMNI" is larger than the lettering for "by OCULAR SCIENCE". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".
Goods and ServicesOphthalmic preparations
Pseudo MarkTIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE OPHTHALMIC SOLUTION ZERO POINT FIVE PERCENT / ZERO POINT TWO PERCENT / TWO PERCENT OMNI BY OCULAR SCIENCE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOcular Science, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90266

Party NameOcular Science, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90266

Trademark Events


Event DateEvent Description
Monday, April 8, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 8, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 20, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 2, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 31, 2018ASSIGNED TO LIE
Wednesday, May 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 16, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, May 16, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 16, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, May 16, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, May 10, 2018ASSIGNED TO EXAMINER
Thursday, March 15, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 10, 2018NEW APPLICATION ENTERED IN TRAM